Literature DB >> 23317549

Predictors of cardiac death in patients with coronary chronic total occlusion not revascularized by PCI.

Cosmo Godino1, Giorgio Bassanelli, Fotios I Economou, Kensuke Takagi, Marco Ancona, Stefano Galaverna, Antonio Mangieri, Valeria Magni, Azeem Latib, Alaide Chieffo, Mauro Carlino, Matteo Montorfano, Alberto Cappelletti, Alberto Margonato, Antonio Colombo.   

Abstract

BACKGROUND: Limited data are available on clinical outcome of patients with previously failed or not attempted chronic total occlusion (CTO) recanalization by percutaneous coronary intervention (PCI). The aim of the study is to determine prevalence and predictors of cardiac death in patients with CTO not revascularized by PCI.
METHODS: Double-center study analyzing data of 1.345 consecutive patients with at least one CTO between 1998 and 2008. Of these, 847 patients were successfully revascularized (Revascularized group) and 498 patients were not revascularized (Not revascularized group) either due to failure of CTO-PCI (n=337) or because no attempt was made (n=161).
RESULTS: At 4-year clinical follow-up, Not revascularized patients had a significantly higher rate of cardiac mortality (8.5% vs. 2.5%, p<0.0001) and sudden cardiac death (2.7% vs. 0.5%, p=0.001) compared to those Revascularized. The separate adjusted Cox-model analysis made for Not revascularized patients showed the most significant independent predictors of cardiac death were: chronic renal failure [HR (CI), 6.0 (2.66-13.80)], low-LVEF [5.7 (2.84-11.58)], insulin-dependent diabetes mellitus (IDDM) 4.6 [(1.96-10.97)]. In the Revascularized group, the presence of 3-vessel disease was the only significant independent predictor of cardiac death [4.4 (1.40-13.70)].
CONCLUSIONS: CTO patients Not revascularized had a significant higher rate of cardiac mortality and sudden cardiac death compared to those Revascularized. Within Not revascularized patients, the presence of low-LVEF, or CRF or IDDM was associated with an incidence of cardiac death at least 4 times higher than those without the same risk factors.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CTO not attempted; CTO not revascularized; Cardiac death; Chronic total occlusion; Sudden death

Mesh:

Year:  2013        PMID: 23317549     DOI: 10.1016/j.ijcard.2012.12.044

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

Review 1.  Long-term clinical outcomes after percutaneous coronary intervention for chronic total occlusions.

Authors:  Spyretta Golemati; Elias A Sanidas; George D Dangas
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

Review 2.  Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention.

Authors:  Cosmo Godino; Antonio Colombo; Alberto Margonato
Journal:  Clin Drug Investig       Date:  2017-02       Impact factor: 2.859

3.  Comparison of long-term outcomes of medical therapy and successful recanalisation for coronary chronic total occlusions in elderly patients: a report of 1,294 patients.

Authors:  Lei Guo; Haichen Lv; Lei Zhong; Jian Wu; Huaiyu Ding; Jiaying Xu; Rongchong Huang
Journal:  Cardiovasc Diagn Ther       Date:  2019-12

4.  The Effect of Recanalization of a Chronic Total Coronary Occlusion on Atrial Conduction Velocities.

Authors:  İsmail Gürbak; Emir Derviş; Cafer Panç; Ahmet Anıl Şahin; Serkan Aslan; Serkan Kahraman; Mehmet Ertürk
Journal:  Acta Cardiol Sin       Date:  2021-07       Impact factor: 2.672

5.  Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion.

Authors:  Jin Kyung Hwang; Jeong Hoon Yang; Ji-Won Hwang; Woo Jin Jang; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Sang Hoon Lee; Hyeon-Cheol Gwon; Seung-Hyuk Choi
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

Review 6.  The evidence base for revascularisation of chronic total occlusions.

Authors:  Alan Bagnall; Ioakim Spyridopoulos
Journal:  Curr Cardiol Rev       Date:  2014-05

7.  First-Generation Versus Second-Generation Drug-Eluting Stents in Coronary Chronic Total Occlusions: Two-Year Results of a Multicenter Registry.

Authors:  Jong-Hwa Ahn; Jeong Hoon Yang; Cheol Woong Yu; Je Sang Kim; Hyun Jong Lee; Rak Kyeong Choi; Tae Hoon Kim; Ho Joon Jang; Young Jin Choi; Young Moo Roh; Won-Heum Shim; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Sang Hoon Lee; Hyeon-Cheol Gwon; Seung-Hyuk Choi
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

8.  Five-Year Outcomes of Successful Percutaneous Coronary Intervention with Drug-Eluting Stents versus Medical Therapy for Chronic Total Occlusions.

Authors:  Seung Woon Rha; Byoung Geol Choi; Man Jong Baek; Yang Gi Ryu; Hu Li; Se Yeon Choi; Jae Kyeong Byun; Ahmed Mashaly; Yoonjee Park; Won Young Jang; Woohyeun Kim; Jah Yeon Choi; Eun Jin Park; Jin Oh Na; Cheol Ung Choi; Hong Euy Lim; Eung Ju Kim; Chang Gyu Park; Hong Seog Seo; Dong Joo Oh
Journal:  Yonsei Med J       Date:  2018-07       Impact factor: 2.759

9.  Long-term Survival Benefit of Statin in Patients with Coronary Chronic Total Occlusion without Revascularization.

Authors:  Bum Sung Kim; Jeong Hoon Yang; Woo Jin Jang; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Ki Hong Choi; Sung-Hea Kim; Woo Jung Chun; Hyeon-Cheol Gwon; Seung-Hyuk Choi
Journal:  J Korean Med Sci       Date:  2018-04-13       Impact factor: 2.153

10.  Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long-Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator (the eCTOpy-in-ICD Study).

Authors:  Ivo M van Dongen; Dilek Yilmaz; Joëlle Elias; Bimmer E P M Claessen; Ronak Delewi; Reinoud E Knops; Arthur A M Wilde; Lieselot van Erven; Martin J Schalij; José P S Henriques
Journal:  J Am Heart Assoc       Date:  2018-05-02       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.